bti320
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 30, 2015 (NCT02358668)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bti320
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03655535 | Phase 1/Phase 2 (Phase 2) | Sep 24, 2018 | Boston Therapeutics |
| NCT02358668 | Phase 2 | Mar 30, 2015 | Boston Therapeutics, Chinese University of Hong Kong |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boston Therapeutics | For profit | 2 | 1 | 1 | 2015 |
| Chinese University of Hong Kong | Academic/Hospital | 1 | 1 | 1 | 2015 |
2 organizations
Page 1 / 1